Earnings Outlook For Myriad Genetics
Portfolio Pulse from Benzinga Insights
Myriad Genetics (NASDAQ:MYGN) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a pattern of share price changes following earnings reports. Shares of Myriad Genetics were trading at $15.98 as of November 2, with a 5.52% increase over the last 52-week period.
November 03, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Myriad Genetics is expected to report an EPS of $-0.08 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports.
The upcoming earnings report is a significant event for Myriad Genetics. While the estimated EPS is negative, the company's share price has shown a general increase over the past year. However, past performance indicates that the company's share price can be affected by its earnings reports, either positively or negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100